Harbourvest Partners’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,484
| Closed | -$39.9K | – | 31 |
|
|
2024
Q3 | $39.9K | Hold |
23,484
| – | – | 0.02% | 31 |
|
|
2024
Q2 | $32.2K | Hold |
23,484
| – | – | 0.02% | 35 |
|
|
2024
Q1 | $88.1K | Hold |
23,484
| – | – | 0.04% | 41 |
|
|
2023
Q4 | $230K | Hold |
23,484
| – | – | 0.08% | 44 |
|
|
2023
Q3 | $196K | Hold |
23,484
| – | – | 0.07% | 48 |
|
|
2023
Q2 | $312K | Hold |
23,484
| – | – | 0.09% | 46 |
|
|
2023
Q1 | $272K | Hold |
23,484
| – | – | 0.09% | 49 |
|
|
2022
Q4 | $192K | Hold |
23,484
| – | – | 0.06% | 51 |
|
|
2022
Q3 | $136K | Hold |
23,484
| – | – | 0.04% | 61 |
|
|
2022
Q2 | $104K | Hold |
23,484
| – | – | 0.03% | 59 |
|
|
2022
Q1 | $214K | Hold |
23,484
| – | – | 0.04% | 61 |
|
|
2021
Q4 | $480K | Hold |
23,484
| – | – | 0.06% | 49 |
|
|
2021
Q3 | $600K | Hold |
23,484
| – | – | 0.06% | 42 |
|
|
2021
Q2 | $821K | Hold |
23,484
| – | – | 0.08% | 36 |
|
|
2021
Q1 | $782K | Buy |
+23,484
| New | +$782K | 0.1% | 25 |
|